ReadyCure
CompanySouth Korea
ReadyCure develops one asset, in human trials (HeLaXON 1X in Alzheimer's disease). Mostly device; based in South Korea.
- 1
- Asset
- Furthest stage
- Human trials
- 1
- Trial
- 3
- Signals
Pipeline
1Delivers low-dose radiation to treat mild Alzheimer's dementia.
Human trials, Device, Alzheimer's disease, mental and behavioural disorders
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials1
- Signals3
- Similar companies6